Chloë M. Stanton

Drug Approval for the Treatment of Geographic Atrophy: How We Got Here and Where We Need to Go

Gene Editing for CEP290 -Associated Retinal Degeneration

Late‐onset retinal degeneration pathology due to mutations in CTRP5 is mediated through HTRA1

Novel pathogenic mutations in C1QTNF5 support a dominant negative disease mechanism in late-onset retinal degeneration